Drug
Idraparinux clinical trials
How studies write it
Studies that test it under each name
By phase
A phase 1/2 study counts in both.
- Phase 3
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses idraparinux is read from its arms, and is right about nine times in ten.
Testing it · 4
- Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation (AMADEUS)CompletedPhase 3SanofiNCT00070655Written as SR34006 (idraparinux sodium) Injection
- SR34006 Compared to Placebo in Patients Who Have Completed 6 Months of Treatment for Symptomatic Pulmonary Embolism or Deep Vein ThrombosisCompletedPhase 3SanofiNCT00071279Written as SR34006 (idraparinux sodium) Injection
- Safety and Efficacy Trial Evaluating the Use of SR34006 in the Treatment of Deep Vein Thrombosis (DVT)CompletedPhase 3SanofiNCT00067093Written as SanOrg34006
- SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary EmbolismCompletedPhase 3SanofiNCT00062803Written as SR34006
As the comparator · 1 — what is tested is compared with idraparinux
Codes
What other systems call idraparinux · ClinicalTrials.gg INT004596
- MeSH (NLM) C479958idraparinuxConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 6ADD3H8MFZIDRAPARINUXConfirmed NLM, Wikidata
- Wikidata Q27890502idraparinuxConfirmed NLM, Wikidata
- DrugBank DB06406One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C479958 | idraparinux | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 6ADD3H8MFZ | IDRAPARINUX | Confirmed NLM, Wikidata |
| Wikidata | Q27890502 | idraparinux | Confirmed NLM, Wikidata |
| DrugBank | DB06406 | — | One source Wikidata |
Also registered as idraparinux sodium (UNII H84IXP29FN).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.